Complex Regulatory Networks Governing Production of the Glycopeptide A40926
Glycopeptides (GPAs) are an important class of antibiotics, with vancomycin and teicoplanin being used in the last 40 years as drugs of last resort to treat infections caused by Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus. A few new GPAs have since reached the mark...
Saved in:
Main Authors: | Rosa Alduina (Author), Margherita Sosio (Author), Stefano Donadio (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2018-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cross-Talking of Pathway-Specific Regulators in Glycopeptide Antibiotics (Teicoplanin and A40926) Production
by: Andrés Andreo-Vidal, et al.
Published: (2023) -
The Impact of Heterologous Regulatory Genes from Lipodepsipeptide Biosynthetic Gene Clusters on the Production of Teicoplanin and A40926
by: Kseniia Zhukrovska, et al.
Published: (2024) -
Glycopeptide Hypersensitivity and Adverse Reactions
by: Vanthida Huang, et al.
Published: (2020) -
Mechanisms of Resistance to Glycopeptides in Staphylococcus aureus
by: Maribel Castellano González, et al.
Published: (2010) -
New Antimicrobial Resistance Strategies: An Adaptive Resistance Network Conferring Reduced Glycopeptide Susceptibility in VISA
by: Elvira Aguglia, et al.
Published: (2023)